QSAR, structure-based pharmacophore modelling and biological evaluation of novel platelet ADP receptor (P2Y 12 ) antagonist

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1<i>N</i>-[6-(4-Butanoyl-5-methyl-1<i>H</i>-pyrazol-1-yl)pyridazin-3-yl]-5-chloro-1-[2-(4-methylpiperazin-1-yl)-2-oxoethyl]-1<i>H</i>-indole-3-carboxamide (SAR216471), a Novel Intravenous and Oral, Reversible, and Directly Acting P2Y12 Antagonist2014 · 50 citations
2. 2Biology and Pharmacology of the Platelet P2Y12 Receptor2006 · 179 citations
3. 3The platelet P2Y12 receptor for adenosine diphosphate: congenital and drug-induced defects2010 · 192 citations
4. 4P2Y ₁₂ Antagonism2008 · 108 citations
5. 5P2Y12 Inhibition beyond Thrombosis: Effects on Inflammation2020 · 101 citations